Evidence map›Paper›PMID 34683873›Full record

ArticlePharmaceutics2021

Physiologic Effects of Instilled and Aerosolized Surfactant Using a Breath-Synchronized Nebulizer on Surfactant-Deficient Rabbits.

Robert M DiBlasi, Kellie J Micheletti, Joseph D Zimmerman, Jonathan A Poli, James B Fink, Masaki Kajimoto

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Journal of aerosol medicine and pulmonary drug delivery · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Robert M DiBlasiDepartment of Respiratory Care, Seattle Children's Hospital, Seattle, WA 98105, USA.
Kellie J MichelettiDepartment of Respiratory Care, Seattle Children's Hospital, Seattle, WA 98105, USA.
Joseph D ZimmermanDepartment of Respiratory Care, Seattle Children's Hospital, Seattle, WA 98105, USA.
Jonathan A PoliCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
James B FinkAerogen Pharma Corporation, San Mateo, CA 94402, USA.
Masaki KajimotoCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.ORCID 0000-0001-9377-1354
Seattle Children's Hospital · USRush University Medical Center · US

Funding

Aerogen Pharma NA
6 · The paper itself

Abstract

Surfactant administration incorporates liquid bolus instillation via endotracheal tube catheter and use of a mechanical ventilator. Aerosolized surfactant has generated interest and conflicting data related to dose requirements and efficacy. We hypothesized that aerosolized surfactant with a novel breath-actuated vibrating mesh nebulizer would have similar efficacy and safety as instilled surfactant. Juvenile rabbits (1.50 ± 0.20 kg,

Indexed as

aerosolnebulizersRDSsurfactant

Identifiers

PMID34683873
PMCPMC8540270
OpenAlexW3202426378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.